Neuroendocrine considerations in the treatment of men and women with epilepsy - Wikidata - wikimedia - TriplyDB

Neuroendocrine considerations in the treatment of men and women with epilepsy

Neuroendocrine considerations in the treatment of men and women with epilepsy

http://www.wikidata.org/entity/Q37055791

about

Women with epilepsy: clinically relevant issues Levetiracetam in Men With Epilepsy: Testosterone Is Left Alone But Sperm Count Is Paramount.Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry.Having Catamenial Epilepsy Equals Fewer Seizures in Pregnancy Association between estrus and onset of seizures in dogs with idiopathic epilepsy.2014 Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across The Lifespan Age-specific birth rates in women with epilepsy: a population-based study.Epilepsy and menopause: potential implications for pharmacotherapy.A Treatment Approach to Catamenial Epilepsy.Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain.Women with epilepsy Multi-day rhythms modulate seizure risk in epilepsy.Gene expression profile analysis in epilepsy by using the partial least squares method.Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy Changes in the Blood-Brain Barrier Function Are Associated With Hippocampal Neuron Death in a Kainic Acid Mouse Model of Epilepsy

P2860

Q30245064-E759EE53-7C7D-445A-ABC4-56147FFBB2A7 Q33636014-528CB468-927C-4F4E-9150-BA8539E7FDDD Q35070885-9DB9783F-1050-4350-B9AD-3C2BF964975C Q35923056-B633C78E-7C7B-4224-8CCE-D2D165E6BAA3 Q36873656-F6294FDA-DE1D-4B82-BDBE-0C01F480015B Q37021068-853AE9B8-55EC-4CEE-B26B-7B4C3BB402B4 Q37166187-AC2F5D10-C423-4734-B936-F9B35D69FDD7 Q38235605-E7672A0E-A8DC-43BB-990F-92E6E7676BB3 Q38836618-E2D715F9-697C-41B3-AD92-40B9BF893943 Q41533636-0470F641-4E86-4ABD-957D-09AA9A5A5F55 Q42366023-3294AE72-DE02-49BD-8A0F-845A1C747827 Q47192920-5EB4CA7D-8DC6-4717-8227-C16F20724E36 Q54960355-83BFB1AA-2DDC-442C-AA77-6DF1420E0AF2 Q57543941-2F652E7D-CFC1-4649-9BAA-C564A612B773 Q58746449-AC225972-0F7D-4814-A77A-2778D5A775D4

P2860

Neuroendocrine considerations in the treatment of men and women with epilepsy

http://www.wikidata.org/entity/Q37055791

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuroendocrine considerations in the treatment of men and women with epilepsy

@en

Neuroendocrine considerations in the treatment of men and women with epilepsy.

@nl

type

label

Neuroendocrine considerations in the treatment of men and women with epilepsy

@en

Neuroendocrine considerations in the treatment of men and women with epilepsy.

@nl

prefLabel

Neuroendocrine considerations in the treatment of men and women with epilepsy

@en

Neuroendocrine considerations in the treatment of men and women with epilepsy.

@nl

P1433

Q37055791-70CAAABA-DF5C-4E05-8424-074CC0C9699B

P1476

Q37055791-28862861-973A-485C-9AA2-5AFDFF26024D

P2093

Q37055791-4741C509-C4F6-4436-9359-DAB82240A211

Q37055791-6DFF523C-B88B-478B-8346-C4B5657881FA

P2860

Q37055791-03646FE3-4A9B-43F1-BEA3-A15BB671C14B

Q37055791-0370FDF5-AD10-4639-B94D-190A30D1B9C4

Q37055791-0755C852-B639-4F48-953A-A068A6CA53EA

Q37055791-081CD044-7102-4352-BCD9-F9810EE8508F

Q37055791-08F95962-1742-4CEE-9B6D-8DAFD0C0ADC9

Q37055791-0AEE0C6F-8737-436C-A298-D41F96ACD64A

Q37055791-0F61F592-70C8-4A9D-8A9C-2C978FFE896F

Q37055791-0FD3C24A-C6C7-44B4-B3EF-7363C0EAEC22

Q37055791-120EE8EC-00EB-4D42-83C9-72C42F604A7A

Q37055791-2660B494-4337-41A4-B4C0-3858FE069943

P304

Q37055791-8B2593A8-D2D5-41DA-B3B2-C9DAA5C49118

P31

Q37055791-A5CD0215-F257-465E-A7E6-171AFC4E12BC

Q37055791-d6f57572-3e88-4a29-9a83-eb6c9076d0fa

P356

Q37055791-043AC13A-610F-438F-8F3E-5C827622E442

P433

Q37055791-097E3375-AC02-472E-9C22-D7FC4A8E8BEF

P478

Q37055791-E62EE9BC-FDE0-423E-9101-8B91943ED6C2

P577

Q37055791-44E8CD2E-F75D-4154-BD1B-2E65608F6BBB

P5875

Q37055791-3D8656B5-8FC2-4C35-9C97-3EDAD2A36355

P698

Q37055791-11B234C7-FBC4-4808-8F5D-BFD97BF3099C

P932

Q37055791-1D98DA78-1646-47AB-8AAC-20059E32C556

P356

S1474-4422(12)70239-9

P1433

Lancet Neurology

P1476

Neuroendocrine considerations in the treatment of men and women with epilepsy

@en

P2093

Cynthia L Harden

http://www.w3.org/2001/XMLSchema#string

Page B Pennell

http://www.w3.org/2001/XMLSchema#string

P2860

Use of serum prolactin in diagnosing epileptic seizures: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Anticonvulsant activity of androsterone and etiocholanolone.

Neurosteroids: endogenous role in the human brain and therapeutic potentials

Female reproductive steroids and neuronal excitability

Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat

In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9)

Interictal and postictal alterations of pulsatile secretions of luteinizing hormone in temporal lobe epilepsy in men.

Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial.

Interictal and postictal circadian and ultradian luteinizing hormone secretion in men with temporal lobe epilepsy.

Circalunar and ultralunar periodicities in women with partial seizures.

P304

72-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(12)70239-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233913575

http://www.w3.org/2001/XMLSchema#string

P698

23237902

http://www.w3.org/2001/XMLSchema#string

P932

4928713

http://www.w3.org/2001/XMLSchema#string